PAR 0.00% 23.0¢ paradigm biopharmaceuticals limited..

MADE IN GERMANY, page-11

  1. 4,285 Posts.
    lightbulb Created with Sketch. 6802
    Saundersdjs,
    Yes this line of thinking has also been pondered over (at least twice in the past!)...Bene's area of expertise is Manufacturing. They have no interest in sales, in running clinical trials. They do what they do, and they are the best at it. They take a small royalty and that's enough for them. Sure I cant speak on their behalf but from the people I have chatted to that have had dealings with them, that's the feeling and impression I get.

    PAR have a wonderfully close relationship with Bene and there is mutual respect and a great partnership there. Paul has mentioned it a couple of times both directly and also on publicly available sources too (eg interviews/AGM etc).


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢
Change
0.000(0.00%)
Mkt cap ! $80.45M
Open High Low Value Volume
23.5¢ 24.0¢ 22.5¢ $165.2K 713.3K

Buyers (Bids)

No. Vol. Price($)
2 12486 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 5000 1
View Market Depth
Last trade - 11.29am 23/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.